Global X Artificial Intelligence & Technology ETF vs Cronos Group Inc — how do they compare? Global X Artificial Intelligence & Technology ETF trades at $63.67, while Cronos Group Inc trades at $3.07 (market cap $1.14B). Which is the better fit depends on your goals.
| AIQ | CRON | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $70.14 | $3.27 |
52-Week Low | $43.88 | $2.30 |
Market Cap | — | $1.14B |
Enterprise Value | — | $341.13M |
Signals from Pluang's Aura AI — not financial advice
AIQ trades at $63.69, up 0.28% today, with a bullish technical signal from moving averages and a neutral stance from oscillators. The stock recently crossed above its 200-day moving average of $56.52, indicating positive momentum. Recent news highlights AIQ's outperformance versus the Nasdaq and its role in the AI investment theme, though financial ratios are not provided in the snapshot.
The outlook for AIQ is tied to the AI sector's growth, with potential from thematic exposure and rebalancing strategies. Risks include high fees, sector volatility, and dependence on AI adoption trends. Analyst sentiment is mixed, with some praising diversification benefits while others note valuation concerns amid rapid gains.
CRON trades at $3.00, down 3.23% today, with a bullish technical signal from moving averages. The company showed strong Q2 2026 performance with 58% YoY revenue growth and earnings beat, though recent quarters were mixed. Valuation metrics include P/E of 16.21 and P/S of 6.55, while profitability improved with 45.86% gross margin. Analyst consensus is mixed with 20% buy, 60% hold ratings.
Outlook remains positive due to international expansion and strong product positioning, particularly in Canada and Europe. Key risks include competitive pressures and cash flow volatility from aggressive investing. The stock presents growth potential but requires monitoring of execution and market conditions.
Trailing returns across standard periods
Latest headlines on both assets
AIQ invests in companies that benefit from the development and utilization of artificial intelligence. It focuses on hardware, software, and data giants at the center of the AI revolution, including NVIDIA, Meta, and Broadcom.
Read more on AIQ →Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →